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Résumé en
anglais
The aim of this work was to compare the osteogenicity of calcium phosphate ceramic
granules with autologous bone graft in ectopic and orthotopic sites. Biphasic calcium
phosphate (BCP) granules composed of hydroxyapatite (HA) and β-tricalcium
phosphate (β-TCP) in a 60/40 ratio were sintered at 1050, 1125 and 1200 °C,
producing different microporosities. Either BCP ceramic granules or autologous
bone chips (n = 7) were implanted into paraspinal muscles. Osteoinduction was not
observed in either the BCP implants or autologous bone chips after 6 or 12 weeks in
the ectopic sites. Hollow and bored polytetrafluoroethylene (PTFE) cylinders were
filled with autologous bone, BCP granules or left empty, then implanted into critical-
sized defects in femoral epiphyses. The PTFE cylinders left empty contained marrow
and blood vessels but not mineralized bone, indicating that this model prevented
bone ingrowth (0.56 ± 0.43% at 12 weeks). Bone formation was observed in contact
with the BCP1050 and BCP1125 granules in the femoral sites after 6 weeks. The
amount of bone after 12 weeks was 5.6 ± 7.3 and 9.6 ± 6.6% for BCP1050 and
BCP1125, respectively. Very little bone formation was observed with the BCP1200
implants (1.5 ± 1.3% at 12 weeks). In both the ectopic and orthotopic sites,
autologous bone chips were drastically resorbed (from 19.4 ± 3.7% initially to 1.7 ±
1.2% at 12 weeks). This study shows that synthetic bone substitutes may have
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